Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Goal: Support reduction of fat mass and enhance fat oxidation over time [1] [4]
The FDA found no clinical studies or publicly available human exposure data for administered MOTS-c, no adequate toxicology, uncertain characterisation and unresolved immunogenicity.[6] The same caution applies to a large range of other non-GLP-1-related peptides that are promoted well beyond the supporting human evidence and in the absence of adequate safety data.[8] Unapproved peptides are not included in the Australian Register of Therapeutic Goods and have not been evaluated by the TGA for safety, quality or effectiveness
Flowchart on Selection of Articles Grading of level of evidence and strength of recommendation was based on strength of recommendation taxonomy (SORT) framework (1
Your body gives you signals when something is off
US$ 21.77
US$ 27.73
US$ 24.91
US$ 20.04
US$ 29.27
